tiprankstipranks

Kelly Gold Insider Profile

4 Followers
Kelly Gold, CFO at CAMP4 Therapeutics Corporation, holds 86.47K shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR). Most recently, Kelly Gold Bought ― shares of CAMP4 Therapeutics Corporation on Sep 02, 2026 for an estimated value of $39.60K.
tipranks
Kelly Gold

Kelly Gold
CAMP4 Therapeutics Corporation (CAMP)
CFO

Ranked #28,071 out of 109,030 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+23.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$367K
100.00%
0.00%
A breakdown of Kelly Gold's holdings

Insider Roles

CAMP4 Therapeutics Corporation
(CAMP)
CFO
X4 Pharmaceuticals
(XFOR)
Director
Roles that Kelly Gold holds in companies

Most Profitable Insider Trade

Stock:
CAMP4 Therapeutics Corporation
(CAMP)
Rating:Informative Buy
Date:Sep 11, 2025 - Sep 11, 2026
Return:+52.80%
The most profitable trade made by Kelly Gold

Kelly Gold's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CAMP4 Therapeutics Corporation
Sep 02, 2026
CFO
Informative Buy
39.60K
$367.48K
X4 Pharmaceuticals
Director
List of latest transactions for each holding click on a transaction to see Kelly Gold's performance on stock

Kelly Gold insider profile FAQ

What is the percentage of profitable transactions made by Kelly Gold?
The percentage of profitable transactions made by Kelly Gold is 100%.
    What is the average return per transaction made by Kelly Gold?
    The average return per transaction made by Kelly Gold is 23.50%.
      What stocks does Kelly Gold hold?
      Kelly Gold holds: CAMP, XFOR stocks.
        What was Kelly Gold’s latest transaction?
        Kelly Gold latest transaction was an Informative Buy of $39.60K.
          What was Kelly Gold's most profitable transaction?
          Kelly Gold’s most profitable transaction was an Informative Buy of CAMP stock on September 11, 2025. The return on the trade was 52.80%.
            What is Kelly Gold's role in CAMP4 Therapeutics Corporation?
            Kelly Gold's role in CAMP4 Therapeutics Corporation is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.